Akin Gump represented Nantahala Capital Management on the deal. Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare...
Soleno Therapeutics’ $60 Million Financing Commitment
BioPharma Credit’s $300 Million Loan to LumiraDx
Akin Gump Strauss Hauer & Feld LLP advised BioPharma Credit PLC on the deal, while Dechert LLP advised Pharmakon Advisors LP. LumiraDx has secured new financing commitments...